Clinical Trial Update: Comparing Efficacy and Safety of Inhaled SNG001 to Placebo [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing inhaled SNG001 with placebo in asthma has completed, evaluating efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SNG001 (Interferon beta-1a (inhaled formulation))

Snippet

Sponsor: Synairgen Research Ltd. | Conditions: Asthma | Phase 2 | Status: COMPLETED